Table 2

ADI fold changes

10-1 nM

1 nM-100 pM

100-10 pM

10-1 pM

1-0.1 pM






Fold

SE

Fold

SE

Fold

SE

Fold

SE

Fold

SE


Prokaryotic targets only

LysX-5_at

1.55

0.18

1.65

0.17

3.84

0.68

9.53

1.99

10.22

3.16

LysX-M_at

1.14

0.22

1.45

0.22

4.06

0.73

8.73

2.31

10.18

2.83

LysX-3_at

1.38

0.23

1.25

0.13

2.74

0.43

7.97

1.83

9.82

2.14

PheX-5_at

1.44

0.24

1.43

0.15

2.74

0.24

6.90

0.94

10.23

1.96

PheX-M_at

1.29

0.27

1.38

0.18

2.46

0.24

7.66

0.88

9.69

1.65

PheX-3_at

1.22

0.34

1.15

0.21

2.24

0.33

7.18

1.21

9.03

1.57

DapX-5_at

1.53

0.19

1.76

0.25

4.30

0.87

8.65

1.99

8.97

1.89

DapX-M_at

1.35

0.24

1.62

0.17

3.84

0.66

8.50

2.14

10.22

2.33

DapX-3_at

1.14

0.20

1.76

0.23

4.19

0.75

8.85

1.93

10.18

2.60

ThrX-5_at

1.36

0.39

1.56

0.28

3.72

0.66

8.38

1.82

10.52

2.34

ThrX-M_at

1.33

0.23

1.56

0.20

4.06

0.75

9.04

2.05

9.96

2.92

ThrX-3_at

0.99

0.40

1.12

0.29

2.94

0.60

8.25

2.31

10.10

2.83

Fixed eukaryotic background

LysX-5_at

1.45

0.22

2.76

0.44

6.48

1.25

9.58

1.91

8.21

2.20

LysX-M_at

0.94

0.16

2.19

0.43

7.15

1.72

6.99

1.97

3.39

0.82

LysX-3_at

1.10

0.14

1.53

0.22

5.37

0.96

6.71

1.20

4.83

0.79

PheX-5_at

1.10

0.11

1.93

0.25

4.55

0.32

9.28

1.26

29.65

6.72

PheX-M_at

1.05

0.17

1.49

0.21

4.63

0.65

9.75

1.20

34.84

20.84

PheX-3_at

0.98

0.15

1.59

0.27

6.12

0.88

9.75

1.46

22.89

4.01

DapX-5_at

1.25

0.15

2.88

0.49

5.87

1.28

9.59

2.59

6.25

2.55

DapX-M_at

1.08

0.15

2.57

0.45

6.01

1.33

8.00

1.41

2.28

0.18

DapX-3_at

1.12

0.11

2.63

0.46

9.26

1.32

8.25

1.99

175.29

16.17

ThrX-5_at

1.11

0.17

2.09

0.37

6.14

1.34

7.90

1.57

7.37

1.26

ThrX-M_at

1.12

0.14

2.19

0.37

6.35

1.40

9.98

1.86

24.77

24.52

ThrX-3_at

0.63

0.10

1.75

0.33

5.31

0.73

9.62

2.01

11.32

1.11


The table shows ADI fold changes between consecutive tenfold dilutions (excluding negative ADIs) and standard errors in the absence (upper) and presence (lower) of 0.5 g/l eukaryotic background.

Chudin et al. Genome Biology 2001 3:research0005.1   doi:10.1186/gb-2001-3-1-research0005

Open Data